ES2125202B1 - Adn recombinante que codifica para epitopos del alergeno profilina util para el diagnostico y tratamiento de alergias. - Google Patents

Adn recombinante que codifica para epitopos del alergeno profilina util para el diagnostico y tratamiento de alergias.

Info

Publication number
ES2125202B1
ES2125202B1 ES9701390A ES9701390A ES2125202B1 ES 2125202 B1 ES2125202 B1 ES 2125202B1 ES 9701390 A ES9701390 A ES 9701390A ES 9701390 A ES9701390 A ES 9701390A ES 2125202 B1 ES2125202 B1 ES 2125202B1
Authority
ES
Spain
Prior art keywords
diagnosis
allergen
treatment
allergies
recombinant dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9701390A
Other languages
English (en)
Other versions
ES2125202A1 (es
Inventor
Ortega Juan Andres Asturias
Garate Alberto Martinez
Quesada Jorge Martinez
Pelaez Ricardo Palacios
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roxall Medicina Espana SA
Original Assignee
Bial Industrial Farmaceutica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bial Industrial Farmaceutica SA filed Critical Bial Industrial Farmaceutica SA
Priority to ES9701390A priority Critical patent/ES2125202B1/es
Priority to PCT/ES1998/000175 priority patent/WO1998059052A1/es
Publication of ES2125202A1 publication Critical patent/ES2125202A1/es
Application granted granted Critical
Publication of ES2125202B1 publication Critical patent/ES2125202B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56961Plant cells or fungi
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/415Assays involving biological materials from specific organisms or of a specific nature from plants

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

ADN recombinante que codifica para epítopos del alérgeno profilina útil para el diagnóstico y tratamiento de alergias. Las moléculas de ADN recombinante codifican para un polipéptido que tiene al menos un epítopo del alérgeno profilina de plantas seleccionadas del grupo formado por Cynodon dactylon, Phleum pratense, Parietaria judaica, Helianthus annuus, Olea europaea y Mercurialis annua. El polipéptido se obtiene cultivando un organismo hospedador conteniendo el vehículo de expresión microbiano correspondiente. Aplicación en el tratamiento y diagnóstico de determinadas alergias.
ES9701390A 1997-06-24 1997-06-24 Adn recombinante que codifica para epitopos del alergeno profilina util para el diagnostico y tratamiento de alergias. Expired - Fee Related ES2125202B1 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES9701390A ES2125202B1 (es) 1997-06-24 1997-06-24 Adn recombinante que codifica para epitopos del alergeno profilina util para el diagnostico y tratamiento de alergias.
PCT/ES1998/000175 WO1998059052A1 (es) 1997-06-24 1998-06-18 Adn recombinante que codifica para epitopos del alergeno profilina util para el diagnostico y tratamiento de alergias

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9701390A ES2125202B1 (es) 1997-06-24 1997-06-24 Adn recombinante que codifica para epitopos del alergeno profilina util para el diagnostico y tratamiento de alergias.

Publications (2)

Publication Number Publication Date
ES2125202A1 ES2125202A1 (es) 1999-02-16
ES2125202B1 true ES2125202B1 (es) 2000-03-16

Family

ID=8299805

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9701390A Expired - Fee Related ES2125202B1 (es) 1997-06-24 1997-06-24 Adn recombinante que codifica para epitopos del alergeno profilina util para el diagnostico y tratamiento de alergias.

Country Status (2)

Country Link
ES (1) ES2125202B1 (es)
WO (1) WO1998059052A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2838556T3 (en) * 2012-04-16 2017-04-10 Alk-Abelló As Plant profile polypeptides for use in non-specific allergy immunotherapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992003551A1 (en) * 1990-08-13 1992-03-05 Biomay Biotechnik Produktions- Und Handelsgesellschaft M.B.H. Birch pollen allergen p14 for diagnosis and therapy of allergic diseases

Also Published As

Publication number Publication date
ES2125202A1 (es) 1999-02-16
WO1998059052A1 (es) 1998-12-30

Similar Documents

Publication Publication Date Title
BR0111125A (pt) Moléculas de ácido nucléico de nrg-2, polipeptìdeos, e métodos diagnóstico e terapêuticos
DK0994728T3 (da) Rekombinante antistoffer, som er specifikke for beta-amyloide ender, DNA, der koder derfor, samt fremgangsmåder til anvendelse heraf
ES2531204T3 (es) Anticuerpo modificado
DK1706424T3 (da) FC-region varianter
DE69636487D1 (de) Zusammensetzungen zur Immuntherapie und Diagnose von Tuberculosis
CY1109683T1 (el) Αντιγονα του streptococcus pyogenes
CY1111958T1 (el) Θεραπευτικη χρηση αντισωματων anti-csi
AR001778A1 (es) Anticuerpo monoclonal antiintegrinas alfa-v linea de celulas de hibridoma que produce este anticuerpo secuencias de adn que codifican para este anticuerpo composición farmacéutica a base del anticuerpo y un procedimiento para producir dicho anticuerpo
ATE382053T1 (de) System zur antikörperexpression und- synthese
ATE510011T1 (de) Neue pilzproteine und diese codierende nukleinsäuren
ATE496134T1 (de) Multigene vectoren und methoden für eine erhöhte expression von rekombinanten polypeptiden
DE69435038D1 (de) Aktivin rezeptor-ähnliche kinase (alk), gehörend zur tgf rezeptorfamilie und/oder zur bmp rezeptorfamilie
PE20211214A1 (es) Variantes de pertuzumab y su evaluacion
ATE195346T1 (de) Rekombinante dna moleküle die aminopeptidase enzyme kodieren und ihre anwendung für die herstellung von impfstoffen gegen helminth infektionen
DE69117949D1 (de) Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis
PE20191614A1 (es) Anticuerpo humanizado para tratar o prevenir trastornos cognitivos, proceso para producirlo, y agente para tratar o prevenir trastornos cognitivos usandolo
DE60226182D1 (de) Agarase und Gen dafür
PE20021098A1 (es) ANTICUERPOS ESPECIFICOS DE CD44v6
ATE516351T1 (de) Verfahren zur molekularen evolution der proteinfunktion in vitro
ES2125202B1 (es) Adn recombinante que codifica para epitopos del alergeno profilina util para el diagnostico y tratamiento de alergias.
DK1660118T3 (da) Fremgangsmåde til identifikation af regulatoriske TR1-lymfocytter gennem nærværet og overekspressionen af specifikke molekyler og anvendelser heraf
ES2069742T3 (es) Proteina de la capsida del calicivirus felino y secuencia nucleotida.
BR0317161A (pt) Moléculas de ligação nogo a e uso farmacêutico das mesmas
ATE417112T1 (de) Steigerung der immunantwort unter verwendung von zielgerichteten molekülen
ATE496129T1 (de) Von hla-klasse-ii-molekülen präsentierte ssx-2- peptide

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19990216

Kind code of ref document: A1

Effective date: 19990216

PC2A Transfer of patent
FD2A Announcement of lapse in spain

Effective date: 20180807